903577-47-9

Basic information

• Product Name: 2-(15-Hydroxypentadecyl)benzene-1,4-diol
• CAS NO: 903577-47-9
• Molecular Weight: 336.515
• Mol File: 903577-47-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(15-Hydroxypentadecyl)benzene-1,4-diol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(15-Hydroxypentadecyl)benzene-1,4-diol(903577-47-9)
• EPA Substance Registry System: 2-(15-Hydroxypentadecyl)benzene-1,4-diol(903577-47-9)

Safety Data

• Hazardous Substances Data: 903577-47-9(Hazardous Substances Data)

Upstream product

• 887604-02-6 (((13-bromotridecyl)oxy)methyl)benzene 
• 505-52-2 brassylic acid 
• 116754-58-6 13-bromo-1-tridecylalcohol 
• 13362-52-2 1,13-tridecanediol 
• 887604-10-6 2-(15-Benzyloxy-pentadec-1-ynyl)-1,4-dimethoxy-benzene 
• 887604-05-9 ((pentadec-14-yn-1-yloxy)methyl)benzene 
• 887604-25-3 15-(2,5-dimethoxyphenyl)pentadecan-1-ol 

Relevant articles and documents

HYDROQUINONE LONG-CHAIN DERIVATIVE AND/OR PHENOXY LONG-CHAIN DERIVATIVE, AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME

The present invention provides compounds represented by formula (1) shown below: (wherein R1, R2, R3, R4, and R5 are each individually selected from among a hydrogen atom, methyl group, acetyl group, hydroxyl group, and alkoxy group; and X represents an alkylene group or alkenylene group); and compounds represented by formula (2) shown below: (wherein R6, R7, R8, R9, and R10 are each individually selected from among a hydrogen atom, alkyl group, acetyl group, hydroxyl group, and alkoxy group; A represents an oxygen atom or NH, and m is 0 or 1; and Y represents an alkylene group or alkenylene group, and Z represents a hydrogen atom or hydroxyl group).The compounds of the present invention are useful for preventing or treating brain dysfunctions, motor dysfunctions, or urinary dysfunctions caused by the degeneration and/or loss of the central nervous system or peripheral nervous system cells.The present invention provides compounds represented by formula (1) shown below: (wherein R 1 , R 2 , R 3 , R 4 , and R 5 are each individually selected from among a hydrogen atom, methyl group, acetyl group, hydroxyl group, and alkoxy group; and X represents an alkylene group or alkenylene group); and compounds represented by formula (2) shown below: (wherein R 6 , R 7 , R 8 , R 9 , and R 10 are each individually selected from among a hydrogen atom, alkyl group, acetyl group, hydroxyl group, and alkoxy group; A represents an oxygen atom or NH, and m is 0 or 1; and Y represents an alkylene group or alkenylene group, and Z represents a hydrogen atom or hydroxyl group). The compounds of the present invention are useful for preventing or treating brain dysfunctions, motor dysfunctions, or urinary dysfunctions caused by the degeneration and/or loss of the central nervous system or peripheral nervous system cells.